Last updated: March 6, 2023
Sponsor: Peking Union Medical College Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neuroendocrine Carcinoma
Treatment
N/AClinical Study ID
NCT05752773
2022-PUMCH-B-0071
Ages 18-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Scheduled for Laparoscopic PPGL resection
Exclusion
Exclusion Criteria:
- Open or laparoscopic conversion to open PPGL resection was excluded
- Cardiac paraganglioma was excluded
- History of congenital heart disease or cardiac surgery was excluded
- Patients with preoperative troponin/hypersensitive troponin elevation were excluded
- Carotid body tumor and accessory ganglioma of jugular tympanum without endocrinefunction were excluded
Study Design
Total Participants: 700
Study Start date:
February 06, 2023
Estimated Completion Date:
May 31, 2025
Study Description
Connect with a study center
Peking Union Medical College Hospital,Chinese Academy of Medical Science and Peking Union Medical College
Beijing, Beijing 100730
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.